Drug innovation and price competition

This study is designed to examine the relationship between drug innovation and price competition. The empirical results presented here support the hypothesis that new drugs-as measured by new chemical entities-exert downward pressure on the prices of existing competitors within the same therapeutic class. The implication of this finding for public policy is that drug innovation not only provides new therapy but also stimulates price competition.